Pain
Researchers sought to examine the relationship between depressive symptoms and pain in U.S. veterans 50 years of age or older.
Multiple Sclerosis
In order to assess asymptomatic infections and immunologic responses to COVID-19, a team of researchers tested for SARS-CoV-2 antibodies in a multiple sclerosis cohort.
Migraine and Headache
Study investigators sought to determine if galcanezumab would reduce not only the frequency of migraine days but also the disabling nonpain symptoms of episodic and chronic migraine.
Sleep Disorders
Longitudinal changes in the dopamine transporter availability may identify patients with idiopathic REM sleep behavior disorder who are at risk of conversion to neurodegenerative diseases.
Multiple Sclerosis
Proinflammatory cytokines, tryptophan catabolites, and the gut-brain axis may have key roles in chronic fatigue and depression in patients with multiple sclerosis.
Alzheimer's Disease and Dementia
Analysis of the HARMONY trial was conducted to evaluate the prevention of relapse in patients with dementia-related psychosis who have been treated with pimavanserin.
Movement Disorders
In early Parkinson Disease, fatigue, excessive daytime sleepiness, and emotional apathy are predictive of increasing fatigue severity.
Epilepsy
Children, adolescents, and young adults have greater risk of self-injurious behavior and suicide ideation if they have a childhood history of epilepsy.
Neurobehavioral Disorders
Depression has been linked to elevated markers of inflammation, and aspirin, a nonsteroid, anti-inflammatory medication, can irreversibly inhibit cyclooxygenase-1 and 2.
Neurobehavioral Disorders
Children who receive a depression diagnosis in their primary school age have a substantially higher risk of a depression relapse during adolescence compared with children who did not receive a depression diagnosis during their primary school age.